SCHEMBL13511

SCHEMBL13511

c1cc2c([nH]1)CCCC2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4065666 0.97 TSHR (0.38)
SCHEMBL31468005 0.97 TSHR (0.38)
SCHEMBL20846254 0.97 TSHR (0.38)
SCHEMBL2778228 0.95
SCHEMBL30927785 0.78 PNMT (0.37)
SCHEMBL30927784 0.78 PNMT (0.37)
SCHEMBL30927783 0.78 PNMT (0.37)
SCHEMBL4288823 0.75 HTR2C (0.48)
SCHEMBL11826056 0.75 PNMT (0.39)
SCHEMBL4878353 0.75 PNMT (0.42)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 689 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3717890-B1 OLEFIN OLIGOMERIZATION METHOD USING ONLINE MEASUREMENT OF CHROMIUM CONCENTRATION IN A CATALYTIC SYSTEM SIBUR HOLDING PUBLIC JOINT STOCK CO (RU) 2024-02-28 EP claimed
EP-4255901-A1 PYRROLE-TYPE COMPOUNDS AND USES THEREOF FOR TREATING VIRAL INFECTIONS ENYO Pharma (FR) 2023-10-11 EP claimed
CN-116490176-A Pyrrole compounds and their use for the treatment of viral infections 埃尼奥制药公司 2023-07-25 CN claimed
CN-114573002-B Mordenite molecular sieve and preparation method and application thereof 中国科学院大连化学物理研究所 2023-06-30 CN claimed
CN-116063309-B Synthesis method of ibrutinib 北京京卫燕康药物研究所有限公司 2023-06-13 CN claimed
CN-116063309-A Synthesis method of ibrutinib 北京京卫燕康药物研究所有限公司 2023-05-05 CN claimed
WO-2023056423-A1 ANDROGEN RECEPTOR MODULATORS AND METHODS FOR USE AS BIFUNCTIONAL DEGRADERS ESSA PHARMA, INC. (CA) 2023-04-06 WO claimed
US-20220380378-A1 ANDROGEN RECEPTOR MODULATORS AND METHODS FOR THEIR USE ESSA PHARMA INC. (CA) 2022-12-01 US claimed
WO-2022226349-A1 ANDROGEN RECEPTOR MODULATORS AND METHODS FOR THEIR USE ESSA PHARMA, INC. (CA) 2022-10-27 WO claimed
WO-2022117697-A1 PYRROLE-TYPE COMPOUNDS AND USES THEREOF FOR TREATING VIRAL INFECTIONS ENYO PHARMA (FR) 2022-06-09 WO claimed
EP-0673782-B1 Recording sheets containing pyrrole, pyrrolidine, pyridine, piperidine, homopiperidine, quinoline, isoquinoline, quinuclidine, indole, and indazole compounds XEROX CORP (US) 2000-06-14 EP claimed
WO-1999048868-A9 HETEROCYCLIC CLASSES OF COMPOUNDS FOR THE MODULATING TYROSINE PROTEIN KINASE SUGEN INC (US) 2000-04-20 WO claimed
WO-2000008202-A2 3-METHYLIDENYL-2-INDOLINONE MODULATORS OF PROTEIN KINASE SUGEN, INC. (US) 2000-02-17 WO claimed
WO-1999048868-A2 HETEROCYCLIC CLASSES OF COMPOUNDS FOR THE MODULATING TYROSINE PROTEIN KINASE SUGEN, INC. (US) 1999-09-30 WO claimed
US-5657064-A Recording sheets containing pyrrole, pyrrolidine, pyridine, piperidine, homopiperidine, quinoline, isoquinoline, quinuclidine, indole, and indazole compounds XEROX CORPORATION (US) 1997-08-12 US claimed
EP-0743573-A2 Method for obtaining image contrast migration imaging members XEROX CORPORATION (US) 1996-11-20 EP claimed
EP-0743574-A2 Migration imaging members XEROX CORPORATION (US) 1996-11-20 EP claimed
US-5563014-A SOFTENABLE LAYER CONTAINIG PHOTOSENSITIVE MARKING MATERIAL; TRANSPARENTIZING AGENT XEROX CORPORATION (US) 1996-10-08 US claimed
US-5514505-A SELECTIVE TRANSPARENTIZATION OF PHOTOSENSITIVE MIGRATION MARKING PARTICLES EMBEDDED NEAR THE SURFACE OF A SOFTENABLE LAYER SUPPORTED BY AN ELECTROCONDUCTIVE SUBSTRATE XEROX CORPORATION (US) 1996-05-07 US claimed
EP-0673782-A2 Recording sheets containing pyrrole, pyrrolidine, pyridine, piperidine, homopiperidine, quinoline, isoquinoline, quinuclidine, indole, and indazole compounds XEROX CORPORATION (US) 1995-09-27 EP claimed